Amerigroup estimates, target cut at Goldman
Shares of AGP now seen reaching $47, according to Goldman Sachs. Estimates also reduced, given lower rate and growth trends. Sell rating.
-----
Amerigroup estimates, target cut at UBS
Shares of AGP now seen reaching $49, according to UBS. Estimates also lowered on higher medical costs. Maintain Neutral rating.
-----
Analog Devices upgraded at UBS
ADI was upgraded from Neutral to Buy, UBS said. $38 price target. Lead indicators for the industrial segment are bottoming.
-----
Applied Materials downgraded at Goldman
AMAT was downgraded from Neutral to Sell, Goldman Sachs said. Valuation call, based on a $10.50 price target.
-----
Autozone target increased at Goldman
AZO target was raised to $313, Goldman Sachs said. Company deserves a premium valuation. Sell rating.
-----
Bed Bath & Beyond target raised at Goldman
Shares of BBBY now seen reaching $62, according to Goldman Sachs. Company's guidance should prove conservative. Neutral rating.
-----
Boardwalk Pipeline upgraded at UBS
BWP was upgraded from Neutral to Buy, UBS said. $28.50 price target. Valuation call.
-----
Colgate-Palmolive added to US1 List at BofA Merrill
CL was added to the US1 List, Bank of America Merrill Lynch said. $100 price target. Fundamentals on an upswing.
-----
Continental Resources target increased at Canaccord
CLR price target raised to $92, Canaccord said. Higher 2H11 oil production outlook. Maintain Buy rating.
-----
Ensco estimates lowered at Canaccord
CLR estimates lowered through 2012, Canaccord said. Unplanned downtime for the Ensco 5006. Maintain $82 price target and Buy rating.
-----
Juniper Networks target cut at Auriga
Shares of JNPR now seen reaching $24, according to Auriga. New product offerings may take longer to ramp. Buy rating.
-----
Kohl's estimates, target reduced at Goldman
Shares of KSS now seen reaching $54, according to Goldman Sachs. Estimates also cut, given new lease accounting Neutral rating.
-----
Lam Research downgraded at Goldman
LRCX was downgraded from Buy to Neutral, Goldman Sachs said. Peak earnings should fall short of expectations. $37 price target.
-----
Linear Technology upgraded at UBS
LLTC was upgraded from Neutral to Buy, UBS said. $34 price target. Compelling risk/reward and bottoming fundamentals.
-----
Maxim Integrated upgraded at UBS
MXIM was upgraded from Neutral to Buy, UBS said. $28 price target. Strong product cycle to offset macro headwinds.
-----
Micron Technology upgraded at Goldman
MU was upgraded from Sell to Neutral, Goldman Sachs said. Supply cuts should help the DRAM business. $6.50 price target.
-----
Micron Technology estimates lowered at UBS
MU estimates lowered through 2012, UBS said. Expect fundamentals to bottom in Q4. Maintain $14 price target and Buy rating.
-----
Netflix estimates, target cut at Goldman
NFLX estimates were reduced through 2013, Goldman Sachs said. Company lowered its subscriber guidance. Buy rating and new $270 price target.
-----
Oracle target lowered at BMO
ORCL price target lowered to $38, BMO Capital Markets said. Mixed operating environment. Maintain Outperform rating.
-----
Oracle target lowered at Think
ORCL price target lowered to $36, ThinkEquity said. Mixed operating environment. Maintain Buy rating.
Quanta Services upgraded at FBR
PWR was upgraded from Underperform to Outperform, FBR Capital Markets said. New Keystone pipeline should help drive near-term growth. $24 price target.
-----
Texas Instruments upgraded at UBS
TXN was upgraded from Neutral to Buy, UBS said. $32 price target. Potential upside from analog and embedded.
-----
Veeco Instruments estimates, target lowered at UBS
Shares of VECO now seen reaching $43, according to UBS. Estimates also lowered as near term Korea weakness may continue. Buy rating.
-----
Walgreens target reduced at Morgan Stanley
WAG target was lowered to $45, Morgan Stanley said. ESRX problem could continue to hang over the stock. Overweight rating.
-----
Warner Chilcott upgraded at Goldman
WCRX was upgraded to Buy, Goldman Sachs said. Valuation call, as the company has an attractive free cash flow yield.
